2YI5
Structural characterization of 5-Aryl-4-(5-substituted-2-4- dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I02 |
Synchrotron site | Diamond |
Beamline | I02 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-05-27 |
Detector | ADSC CCD |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 70.870, 90.310, 88.440 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 47.163 - 2.500 |
R-factor | 0.1993 |
Rwork | 0.195 |
R-free | 0.28930 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | INTERNAL STRUCTURE |
RMSD bond length | 0.011 |
RMSD bond angle | 1.354 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX ((PHENIX.REFINE)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 56.000 | 2.640 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.080 | 0.520 |
Number of reflections | 10079 | |
<I/σ(I)> | 12.2 | 2.3 |
Completeness [%] | 99.6 | 99.6 |
Redundancy | 3.4 | 3.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 7 | pH 7 |